Future research should aim to comprehensively elucidate the role of the IL-6/IL-6R/ERK axis within TME to facilitate the development of more effective, less toxic, and personalised therapeutic strategies for HNSCC. Here, IL6 is linked to head and neck squamous cell carcinoma.